![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Vivera Pharmaceuticals Warned by FDA for Unapproved COVID-19 Tests
Vivera Pharmaceuticals Warned by FDA for Unapproved COVID-19 Tests
Mission Viejo, Calif.-based Vivera Pharmaceuticals has received an FDA warning letter for marketing unapproved tests for the coronavirus that causes COVID-19.
The agency says it visited the company’s websites and found they offered a COVx-RDA Saliva Antigen Test and a COVx-RDA Nasal Antigen Test that were not authorized.
Vivera’s COVID-19 test kits are considered adulterated and misbranded, the agency said, adding that it is taking urgent measures to stop the sale of such products during the pandemic.
Upcoming Events
-
21Oct